P120021S016

None

FDA Premarket Approval P120021 S016

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP120021S016
Classification NameNone
Applicant
PMAP120021
SupplementS016

Supplemental Filings

Supplement NumberDateSupplement Type
P120021Original Filing
S018 2020-05-06 30-day Notice
S017 2020-04-24 30-day Notice
S016
S015 2020-03-19 30-day Notice
S014 2020-03-17 30-day Notice
S013 2019-09-26 30-day Notice
S012 2019-06-24 Normal 180 Day Track No User Fee
S011 2019-02-27 30-day Notice
S010 2019-02-15 Normal 180 Day Track No User Fee
S009 2019-01-03 30-day Notice
S008
S007 2018-02-12 30-day Notice
S006 2018-01-30 Real-time Process
S005
S004 2017-07-06 30-day Notice
S003 2017-01-26 30-day Notice
S002 2016-11-23 Normal 180 Day Track No User Fee
S001 2016-11-17 Normal 180 Day Track No User Fee

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.